Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin

M. Holcomb; S. Safe

doi:10.1016/0304-3835(94)90144-9

Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin

M. Holcomb, S. Safe

Research output: Contribution to journal › Article

88 Scopus citations

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds inhibit diverse estrogen-induced responses in the rodent uterus and human breast cancer cells. The effects of a single non-toxic dose of TCDD (10 μg/kg) on the development of mammary tumors was investigated in female Sprague-Dawley rats treated with an oral dose of 7,12-dimethylbenzanthracene (DMBA) (20 mg). In rats which developed mammary tumors, subsequent treatment with corn oil (vehicle) resulted in a 3.9-fold increase in mammary tumor volume after 21 days. In contrast, a second group of rats with mammary tumors were treated with a non-toxic dose of TCDD (10 μg/kg) and after 21 days, the mean tumor volumes decreased from 89.7 ± 53 mm³ to 24.9 ± 28.5 mm³. Moreover, these results demonstrate the antitumorigenic activity of TCDD in female Sprague-Dawley rats.

Original language	English (US)
Pages (from-to)	43-47
Number of pages	5
Journal	Cancer Letters
Volume	82
Issue number	1
DOIs	https://doi.org/10.1016/0304-3835(94)90144-9
State	Published - Jul 15 1994

Keywords

2,3,7,8-Tetrachlorodibenzo-p-dioxin
Inhibition
Rat mammary tumors

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/0304-3835(94)90144-9

Fingerprint Dive into the research topics of 'Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin'. Together they form a unique fingerprint.

Cite this

@article{fbac80083fc84cbba7870885353cd40c,

title = "Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin",

abstract = "2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds inhibit diverse estrogen-induced responses in the rodent uterus and human breast cancer cells. The effects of a single non-toxic dose of TCDD (10 μg/kg) on the development of mammary tumors was investigated in female Sprague-Dawley rats treated with an oral dose of 7,12-dimethylbenzanthracene (DMBA) (20 mg). In rats which developed mammary tumors, subsequent treatment with corn oil (vehicle) resulted in a 3.9-fold increase in mammary tumor volume after 21 days. In contrast, a second group of rats with mammary tumors were treated with a non-toxic dose of TCDD (10 μg/kg) and after 21 days, the mean tumor volumes decreased from 89.7 ± 53 mm3 to 24.9 ± 28.5 mm3. Moreover, these results demonstrate the antitumorigenic activity of TCDD in female Sprague-Dawley rats.",

keywords = "2,3,7,8-Tetrachlorodibenzo-p-dioxin, Inhibition, Rat mammary tumors",

author = "M. Holcomb and S. Safe",

year = "1994",

month = jul,

day = "15",

doi = "10.1016/0304-3835(94)90144-9",

language = "English (US)",

volume = "82",

pages = "43--47",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin

AU - Holcomb, M.

AU - Safe, S.

PY - 1994/7/15

Y1 - 1994/7/15

N2 - 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds inhibit diverse estrogen-induced responses in the rodent uterus and human breast cancer cells. The effects of a single non-toxic dose of TCDD (10 μg/kg) on the development of mammary tumors was investigated in female Sprague-Dawley rats treated with an oral dose of 7,12-dimethylbenzanthracene (DMBA) (20 mg). In rats which developed mammary tumors, subsequent treatment with corn oil (vehicle) resulted in a 3.9-fold increase in mammary tumor volume after 21 days. In contrast, a second group of rats with mammary tumors were treated with a non-toxic dose of TCDD (10 μg/kg) and after 21 days, the mean tumor volumes decreased from 89.7 ± 53 mm3 to 24.9 ± 28.5 mm3. Moreover, these results demonstrate the antitumorigenic activity of TCDD in female Sprague-Dawley rats.

AB - 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds inhibit diverse estrogen-induced responses in the rodent uterus and human breast cancer cells. The effects of a single non-toxic dose of TCDD (10 μg/kg) on the development of mammary tumors was investigated in female Sprague-Dawley rats treated with an oral dose of 7,12-dimethylbenzanthracene (DMBA) (20 mg). In rats which developed mammary tumors, subsequent treatment with corn oil (vehicle) resulted in a 3.9-fold increase in mammary tumor volume after 21 days. In contrast, a second group of rats with mammary tumors were treated with a non-toxic dose of TCDD (10 μg/kg) and after 21 days, the mean tumor volumes decreased from 89.7 ± 53 mm3 to 24.9 ± 28.5 mm3. Moreover, these results demonstrate the antitumorigenic activity of TCDD in female Sprague-Dawley rats.

KW - 2,3,7,8-Tetrachlorodibenzo-p-dioxin

KW - Inhibition

KW - Rat mammary tumors

UR - http://www.scopus.com/inward/record.url?scp=0028285283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028285283&partnerID=8YFLogxK

U2 - 10.1016/0304-3835(94)90144-9

DO - 10.1016/0304-3835(94)90144-9

M3 - Article

C2 - 8033067

AN - SCOPUS:0028285283

VL - 82

SP - 43

EP - 47

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -